A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung Cancer
Clinical trial NCT04306926 · UNKNOWN
Trial details
- NCT number
- NCT04306926
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2022-10-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.